Stay updated with breaking news from Charless Grob. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
As psychedelic medicine comes further into cancer care, pharmacists will be an important part of the interdisciplinary team in screening and evaluating patients for suitability for psychedelic medicine.
The psychedelic revolution is coming. Psychiatry may never be the same By Andrew Jacobs New York Times,Updated May 9, 2021, 9:24 p.m. Email to a Friend Rick Doblin, director of the Multidisciplinary Association for Psychedelic Studies, a nonprofit research group, at his home in Belmont, Mass. on April 9, 2021. A new study shows that MDMA, the illegal drug known as Ecstasy or Molly, can bring relief when paired with talk therapy to those with severe post-traumatic stress disorder.RONY LUONG/NYT Itâs been a long, strange trip in the four decades since Rick Doblin, a pioneering psychedelics...
E-Mail LOS ANGELES (February 10, 2021) -- The Lundquist Institute has received a $1.75 million grant from the Steven & Alexandra Cohen Foundation to fund a multi-site clinical trial to evaluate the efficacy and safety of the compound psilocybin in individuals with severe psychological distress associated with a terminal medical illness. The grant will also support education and outreach programs related to the use of psilocybin within the field of palliative care. This innovative and first-of-its-kind psychedelic study will be conducted at several leading medical schools and cancer centers ...